All In MedTech

Device Trial Radar · NCT04875104

Upper Sequential Distalization With TADs and Aligners

A Randomized Clinical Trial on Upper Sequential Distalization With Temporary Anchorage Devices (TADs) and Two Aligner Systems

Last checked: Nov 19, 2026Latest source record: Nov 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 392 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

392

Planned (sponsor's estimate)

Start

Nov 2021

Primary completion

May 2022

Study completion Dec 2023

Sponsor

Lead sponsor
Universidad Complutense de MadridAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 6, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In this study the investigators are going to compare the predictability of the backward movement of upper first molars in patients with the upper dentition more advanced than the lower dentition. The investigators are going to study if the movements that they predict are achieved and in which proportion and compare it between four different aligner systems. The investigators hypothesis is that there are no differences in the predictability of this movement between the four aligner systems.

Conditions

  • Malocclusion, Angle Class II
  • Distalization

Interventions

  • Orthodontic treatment with Invisalign systemDevice

    Patients are going to receive an orthodontic treatment with Invisalign aligners.

  • Orthodontic treatment with Spark systemDevice

    Patients are going to receive an orthodontic treatment with Spark aligners.

  • Orthodontic treatment with Quicksmile systemDevice

    Patients are going to receive an orthodontic treatment with Quicksmile aligners.

  • Orthodontic treatment with ClearCorrect systemDevice

    Patients are going to receive an orthodontic treatment with ClearCorrect aligners.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Predictability of upper molar distalizationTime frame: Time 0 (initial day of treatment) to Time 1 (achievement of class I, 10-12 months)
  2. Achievement of molar class ITime frame: Time 0 (initial day of treatment) to Time 1 (achievement of class I, 10-12 months)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Universidad Complutense de Madrid

    Madrid, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.